Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
5.79
+0.02 (0.30%)
Nov 4, 2025, 11:26 AM EST - Market open
Evaxion Market Cap
Evaxion has a market cap or net worth of $36.56 million as of November 4, 2025. Its market cap has increased by 141.84% in one year.
Market Cap
36.56M
Enterprise Value
32.98M
1-Year Change
141.84%
Ranking
Category
Stock Price
$5.79
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $36.56M, a decrease of -80.96%. That is a compound annual growth rate of -29.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 36.45M | 634.93% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | 191.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |